LATIGLUTENASE – AN EFFECTIVE ORAL THERAPY IN DEVELOPMENT FOR THE TREATMENT OF CELIAC DISEASE: EXPLORING THE BENEFITS AND CHALLENGES OF ADMINISTERING AND MEASURING GLUTEN IN A CLINICAL TRIAL SETTING

Jennifer Sealey Voyksner ¹ Jack Syage Joseph Murray ²
¹ ImmunogenX, Inc., Newport Beach, United States
² Mayo Clinic, Rochester, United States

Topic
Small Intestine & Nutrition

Session
Update in coeliac disease

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)

Do you need help setting up your myUEG account?
Contact us at [email protected]

Social Sharing